Influenza antivirals: efficacy and resistance

dc.creatorSiqueira, Marilda Agudo Mendonça Teixeira de
dc.creatorHay, Alan
dc.date2020-05-05T16:12:58Z
dc.date2020-05-05T16:12:58Z
dc.date2013
dc.date.accessioned2023-09-27T00:12:13Z
dc.date.available2023-09-27T00:12:13Z
dc.identifierSIQUEIRA, Marilda: HAY, Alan. Influenza antivirals: efficacy and resistance. Influenza and Other Respiratory Viruses, v. 7, 1p, Suppl. 1, 2012
dc.identifier1750-2659
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/41101
dc.identifier10.1111/irv.12041
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8898484
dc.descriptionThe inaugural conference of the Antiviral Group of the International Society for Influenza and other Respiratory Virus Diseases (ISIRV-AVG) was organised in conjunction with the Oswaldo Cruz Foundation (FIOCRUZ) in Rio de Janeiro, Brazil, in November 2011. The purpose of the meeting was to increase awareness of the antivirals available for combating influenza, of their efficacy and effectiveness in different situations, of policies for use against pandemic and seasonal influenza, and of the limitations posed by development of resistance ...
dc.formatapplication/pdf
dc.languageeng
dc.publisherBlackwell Publishing Ltd
dc.rightsopen access
dc.subjectAntivirais da gripe
dc.subjectEficácia
dc.subjectResistência
dc.subjectInfluenza antivirals
dc.subjectEfficacy
dc.subjectResistance
dc.titleInfluenza antivirals: efficacy and resistance
dc.typeEditorial


Este ítem pertenece a la siguiente institución